Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Changes in Sepsis Biomarkers after Immunosuppressant Administration in Transplant Patients

J. Franeková, M. Protuš, E. Kieslichová, A. Březina, J. Komrsková, J. Vymětalík, A. Jabor

. 2021 ; 2021 (-) : 8831659. [pub] 20210105

Language English Country United States

Document type Journal Article

Sepsis biomarkers change continuously during the postoperative period. We aimed to demonstrate the influence of immunosuppressants after transplantation (Tx) on presepsin, procalcitonin, CRP, white blood cells, and IL-6. A group of 140 patients after major surgery (86 non-Tx, 54 Tx) without any signs of sepsis or infectious complications was followed for 7 days. The changes in biomarkers were analyzed with respect to the type of surgery, organ, and induction immunosuppressant used (antithymocyte globulin, corticosteroids, or basiliximab/rituximab). Concentrations (95th percentiles) of presepsin and procalcitonin were higher in the Tx group (presepsin: Tx < 2380 vs. non-Tx < 1368 ng/L, p < 0.05; procalcitonin: <28.0 vs. 3.49 μg/L, p < 0.05). In contrast, CRP and IL-6 were lower in the Tx group (CRP: Tx < 84.2 vs. non-Tx < 229 mg/L, p < 0.05; IL-6: <71.2 vs. 317 ng/L, p < 0.05). Decreases in CRP and IL-6 were found for all immunosuppressants, and procalcitonin was increased after antithymocyte globulin and corticosteroids. Negligible changes were found for white blood cells. Different responses of presepsin, procalcitonin, CRP, and IL-6 were therefore found in patients without any infectious complications after major surgery or transplantation. Immunosuppression decreased significantly IL-6 and CRP in comparison to non-Tx patients, while procalcitonin was increased after corticosteroids and antithymocyte globulin only. Cautious interpretation of sepsis biomarkers is needed in the early posttransplant period. This work was conducted as a noninterventional (nonregistered) study.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004672
003      
CZ-PrNML
005      
20220127145053.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2021/8831659 $2 doi
035    __
$a (PubMed)33505219
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Franeková, Janka $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic $u Third Faculty of Medicine, Charles University, Ruská 87, 100 00 Prague 10, Czech Republic
245    10
$a Changes in Sepsis Biomarkers after Immunosuppressant Administration in Transplant Patients / $c J. Franeková, M. Protuš, E. Kieslichová, A. Březina, J. Komrsková, J. Vymětalík, A. Jabor
520    9_
$a Sepsis biomarkers change continuously during the postoperative period. We aimed to demonstrate the influence of immunosuppressants after transplantation (Tx) on presepsin, procalcitonin, CRP, white blood cells, and IL-6. A group of 140 patients after major surgery (86 non-Tx, 54 Tx) without any signs of sepsis or infectious complications was followed for 7 days. The changes in biomarkers were analyzed with respect to the type of surgery, organ, and induction immunosuppressant used (antithymocyte globulin, corticosteroids, or basiliximab/rituximab). Concentrations (95th percentiles) of presepsin and procalcitonin were higher in the Tx group (presepsin: Tx < 2380 vs. non-Tx < 1368 ng/L, p < 0.05; procalcitonin: <28.0 vs. 3.49 μg/L, p < 0.05). In contrast, CRP and IL-6 were lower in the Tx group (CRP: Tx < 84.2 vs. non-Tx < 229 mg/L, p < 0.05; IL-6: <71.2 vs. 317 ng/L, p < 0.05). Decreases in CRP and IL-6 were found for all immunosuppressants, and procalcitonin was increased after antithymocyte globulin and corticosteroids. Negligible changes were found for white blood cells. Different responses of presepsin, procalcitonin, CRP, and IL-6 were therefore found in patients without any infectious complications after major surgery or transplantation. Immunosuppression decreased significantly IL-6 and CRP in comparison to non-Tx patients, while procalcitonin was increased after corticosteroids and antithymocyte globulin only. Cautious interpretation of sepsis biomarkers is needed in the early posttransplant period. This work was conducted as a noninterventional (nonregistered) study.
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a C-reaktivní protein $x metabolismus $7 D002097
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunosupresiva $x terapeutické užití $7 D007166
650    _2
$a interleukin-6 $x krev $7 D015850
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a sepse $x krev $7 D018805
655    _2
$a časopisecké články $7 D016428
700    1_
$a Protuš, Marek $u Department of Anesthesiology, Resuscitation, and Intensive Care, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic $u First Faculty of Medicine, Charles University, Kateřinská 1660/32, 121 08 Prague 2, Czech Republic
700    1_
$a Kieslichová, Eva $u Department of Anesthesiology, Resuscitation, and Intensive Care, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic $u First Faculty of Medicine, Charles University, Kateřinská 1660/32, 121 08 Prague 2, Czech Republic
700    1_
$a Březina, Aleš $u Department of Anesthesiology and Resuscitation, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic
700    1_
$a Komrsková, Jitka $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic $u Third Faculty of Medicine, Charles University, Ruská 87, 100 00 Prague 10, Czech Republic
700    1_
$a Vymětalík, Jiří $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic
700    1_
$a Jabor, Antonín $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic $u Third Faculty of Medicine, Charles University, Ruská 87, 100 00 Prague 10, Czech Republic
773    0_
$w MED00006378 $t Mediators of inflammation $x 1466-1861 $g Roč. 2021, č. - (2021), s. 8831659
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33505219 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145050 $b ABA008
999    __
$a ok $b bmc $g 1751977 $s 1155821
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 2021 $c - $d 8831659 $e 20210105 $i 1466-1861 $m Mediators of inflammation $n Mediators Inflamm $x MED00006378
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...